These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3114012)
1. Estrone-3-glucuronide chemiluminescence immunoassay: an alternative method for monitoring induction of ovulation with human menopausal gonadotropin in an in vitro fertilization program. Lessing JB; Peyser MR; Gilad S; Amit A; Kogosowski A; Yovel I; Barak Y; David MP Fertil Steril; 1987 Sep; 48(3):450-3. PubMed ID: 3114012 [TBL] [Abstract][Full Text] [Related]
2. Estrone 3-glucuronide chemiluminescence immunoassay (LIA) and 17beta estradiol radioimmunoassay (RIA) in the monitoring of superovulation for in vitro fertilization (IVF): correlation with follicular parameters and oocyte maturity. Rapi S; Fuzzi B; Mannelli M; Pratesi S; Criscuoli L; Pellegrini S; Messeri G Acta Eur Fertil; 1992; 23(2):63-8. PubMed ID: 1338258 [TBL] [Abstract][Full Text] [Related]
3. Excretion of total estrogens and estrone-3-glucuronide during treatment with human menopausal gonadotropins. Frenkel Y; Eshkol A; Tikotzky D; Mashiach S; Lunenfeld B Eur J Obstet Gynecol Reprod Biol; 1985 Jul; 20(1):27-33. PubMed ID: 3928414 [TBL] [Abstract][Full Text] [Related]
4. Correlation between plasma estradiol and estrone-3-glucuronide in urine during the monitoring of ovarian induction therapy. Catalan R; Castellanos JM; Palomino T; Senti M; Antolin M; Galard RM Int J Fertil; 1989; 34(4):271-5. PubMed ID: 2570765 [TBL] [Abstract][Full Text] [Related]
5. Measurement of glucuronometabolites of 17 beta-estradiol and progesterone in early morning urine samples: a promising new method for the evaluation of hormonal responses of Buserelin-hMG treatment in an IVF program. Pellegrini S; Rapi S; Coccia E; Pieri A; Mannelli M; Buzzoni P Acta Eur Fertil; 1989; 20(4):203-9. PubMed ID: 2519572 [TBL] [Abstract][Full Text] [Related]
6. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles. Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454 [TBL] [Abstract][Full Text] [Related]
7. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase I, 1981. Garcia JE; Jones GS; Acosta AA; Wright G Fertil Steril; 1983 Feb; 39(2):167-73. PubMed ID: 6217993 [TBL] [Abstract][Full Text] [Related]
8. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes. Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722 [TBL] [Abstract][Full Text] [Related]
9. Ovulation prediction: changes in the concentrations of urinary estrone-3-glucuronide, estradiol-17 beta-glucuronide and estriol-16 alpha-glucuronide during conceptional cycles. Branch CM; Collins PO; Collins WP J Steroid Biochem; 1982 Feb; 16(2):345-7. PubMed ID: 7078170 [TBL] [Abstract][Full Text] [Related]
10. Hormone excretion during early pregnancy following spontaneous and clomiphene citrate-induced ovulation. Strigini F; Collins WP; Whitehead MI; Benedetto Melis G; Fioretti P; Campbell S Fertil Steril; 1986 Aug; 46(2):209-14. PubMed ID: 3732527 [TBL] [Abstract][Full Text] [Related]
11. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer. Huang JC; Jackson KV; Hornstein MD; Ginsburg ES J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120 [TBL] [Abstract][Full Text] [Related]
13. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization. Jiang S; Kuang Y Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429 [TBL] [Abstract][Full Text] [Related]
14. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Garcia JE; Padilla SL; Bayati J; Baramki TA Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247 [TBL] [Abstract][Full Text] [Related]
15. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981. Garcia JE; Jones GS; Acosta AA; Wright G Fertil Steril; 1983 Feb; 39(2):174-9. PubMed ID: 6401635 [TBL] [Abstract][Full Text] [Related]
16. Relationship between urinary estrone conjugates as measured by enzyme immunoassay and serum estradiol in women receiving gonadotropins for in vitro fertilization. Alper MM; Halvorson L; Lasley B; Mortola J J Assist Reprod Genet; 1994 Sep; 11(8):405-8. PubMed ID: 7606153 [TBL] [Abstract][Full Text] [Related]
18. Application of rapid and simultaneous measurement of sex steroid hormones to the monitoring of gonadotropin therapy. Hayata K; Hayashi N; Sekiba K Acta Med Okayama; 1985 Jun; 39(3):161-70. PubMed ID: 3927661 [TBL] [Abstract][Full Text] [Related]
19. The association between preovulatory serum 17 beta-estradiol pattern and conception in human menopausal gonadotropin-human chorionic gonadotropin stimulation. Laufer N; DeCherney AH; Tarlatzis BC; Naftolin F Fertil Steril; 1986 Jul; 46(1):73-6. PubMed ID: 3087791 [TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of growth hormone and gonadotropins in achieving conception in "clonidine-negative" patients with unexplained infertility. Blumenfeld Z; Amit T; Barkey RJ; Lunenfeld B; Brandes JM Ann N Y Acad Sci; 1991; 626():250-65. PubMed ID: 1905509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]